References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68: 394-424. View
2. Somdyala NIM, Bradshaw D, Dhansay MA, Stefan DC (2020) Increasing Cervical Cancer Incidence in Rural Eastern Cape Province of South Africa From 1998 to 2012: A Population-Based Cancer Registry Study. JCO Glob Oncol 6: 1-8. View
3. Serrano B, Brotons M, Bosch FX, Bruni L (2018) Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 47: 14-26. View
4. Wang W, Sima N, Kong D, Luo A, Gao Q, et al. (2010) Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Cancer Lett 291: 67-75. View
5. Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, et al. (2008) New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 15: 140-153. View
6. Ohlenschläger O, Seiboth T, Zengerling H, Briese L, Marchanka A, et al. (2006) Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 25: 5953-5959. View
7. Pal A, Kundu R (2020) Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol 10: 3116. View
8. Massad LS, Xie X, Burk R, Keller MJ, Minkoff H, et al. (2014) Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS 28: 2601-2608. View
9. Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, et al. (2007) The Impact of HIV Status and Type on the Clearance of Human Papillomavirus Infection among Senegalese Women. J Infect Dis 196: 887-894. View
10. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, et al. (1990) Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol. 38: 377-382. View
11. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, et al. (2010) Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes View
12. Liu G, Sharma M, Tan N, Barnabas R (2018) HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. AIDS 32: 795-808. View
13. Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, et al. (2003) Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 17: 1963-1968. View
14. Botha MD (2017) Guidelines for cervical cancer screening in South Africa. SAJGO 99: 1. View
15. Prendiville W, Cullimore J, Norman S (1989) Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 96: 1054-1060. View
16. Stevenson M (2021) epiR: Tools for the Analysis of Epidemiological Data version 2.0.38 from CRAN. Accessed October 19, 2021. View
17. Huy NVQ, Tam LM, Tram NVQ, Thuan DC, Vinh TQ, et al. (2018) The value of visual inspection with acetic acid and Pap smear in cervical cancer screening program in low resource settings – A population-based study. Gynecologic Oncology Reports 24: 18-20. View
18. Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, et al. (2012) Comparison of Conventional Cervical Cytology versus Visual Inspection with Acetic Acid (VIA) among HIV-Infected Women in Western Kenya. J Low Genit Tract Dis 16: 92-97. View
19. Monsonego J, Autillo-Touati A, Bergeron C, Dachez R, Liaras J, et al. (2001) Liquid-based cytology for primary cervical cancer screening: a multi-centre study. Br J Cancer 84: 360-366. View
20. Heinonen A, Jakobsson M, Kiviharju M, Virtanen S, Aro K, et al. (2020) Role of Colposcopy after Treatment for Cervical Intraepithelial Neoplasia. Cancers 12: 1683. View
21. Montz FJ, Holschneider CH, Thompson LD (1993) Large-loop excision of the transformation zone: effect on the pathologic interpretation of resection margins. Obstet Gynecol 81: 976-982. View
22. Verguts J, Bronselaer B, Donders G, M Arbyn, J Van Eldere, et al. (2006) Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 113: 1303-1307. View
23. Guzha BT (2021) Long-term outcomes of women treated for high-grade squamous intraepithelial lesions at a University Hospital colposcopy unit in South Africa. A 5-year retrospective cohort study. Accessed October 19, 2021. View
24. Flannelly G, Bolger B, Fawzi H, De Barros Lopes A, et al. (2001) Follow up after LLETZ: could schedules be modified according to risk of recurrence? BJOG 108: 1025-1030. View
25. Mbulawa ZZA, Coetzee D, Williamson AL (2015) Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis 15: 459. View
26. Batra P, Kuhn L, Denny L (2010) Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town : original article. S Afr Med J 100: 39-44. View
27. Konopnicki D, De Wit S, Clumeck N (2013) HPV and HIV coinfection: a complex interaction resulting in epidemiological, clinical and therapeutic implications. Future Virology 8: 903-915. View
28. Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG (2020) The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review. Sys Rev 9: 88. View